MINDY SCOTT: Open Payments
NPI 1063122273 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 28 payments from 9 companies in 2025. Trend: 2023 $367 · 2024 $170 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $175 |
| Otsuka America Pharmaceutical, Inc. | 4 | $141 |
| E.R. Squibb & Sons, L.L.C. | 3 | $87 |
| Teva Pharmaceuticals USA, Inc. | 4 | $64 |
| Alkermes, Inc. | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: VRAYLAR, ABILIFY MAINTENA, COBENFY, ARISTADA, UZEDY, REXULTI, HETLIOZ, SPRAVATO.
Industry payments across IN — which companies pay providers there.
